Market Watch – Page 548 – Biotech Insider

All Posts in "Market Watch"

Oil ends at a nearly 6-week high as new Saudi oil minister repeats commitment to production cuts

U.S., global benchmark crude prices at highest finish since July 31

by Editor — September 10, 2019 By Editor in Market Watch

Dow logs longest win streak in 8 weeks but other indexes slip as tariff, growth woes linger

AT&T shares rise 1.5% on Elliott Management plan

by Editor — September 10, 2019 By Editor in Market Watch

Asian markets gain as investors weigh latest economic data

Nikkei, Shanghai indexes edge up; Hang Seng stays about flat

by Editor — September 09, 2019 By Editor in Market Watch

South Carolina’s Mark Sanford to challenge Trump in 2020 Republican primary

Outspoken Trump critic admits longshot odds, says GOP has lost its way

by Editor — September 09, 2019 By Editor in Market Watch

Head of MIT’s Media Lab resigns over ties to Jeffrey Epstein

Joi Ito tried to conceal extend of fundraising relationship, report found

by Editor — September 09, 2019 By Editor in Market Watch

American consumers are far from spent — and that’s a lifesaver for a wobbly economy

Main Street doing the heavy lifting to keep Wall Street in the money

by Editor — September 09, 2019 By Editor in Market Watch

Here’s how other countries financially support their retirees

Caring for retirees is a problem all over the world — here are some solutions

by Editor — September 08, 2019 By Editor in Market Watch

Gold’s big drop is just the beginning of a longer slide

Gold market-timing sentiment is overly bullish

by Editor — September 08, 2019 By Editor in Market Watch

Central bankers now know: hang together or most assuredly hang separately

Central Bank coordination has morphed into co-dependency

by Editor — September 08, 2019 By Editor in Market Watch

Silicon Valley’s final frontier for mobile payments — ‘the neoliberal takeover of the human body’

Ditching credit cards for facial recognition will remove the last physical barrier between our bodies and Corporate America

by Editor — September 08, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.